Stock Analiz

LifeStance Health Group, Inc. (LFST) financials: revenue, earnings and cash flow

Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

LifeStance Health Group’s revenue went from $213M in fiscal 2019 to $1.4B in fiscal 2025, growth of about 37.3% a year.

Net income in fiscal 2025 was $10M, a net margin of 0.7%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $1.7B and net income $72M.

Free cash flow was $110M in fiscal 2025 and positive in 3 of the 6 years shown.

Revenue, profit and cash flow by year

Revenue
2019: $213M20192021: $668M20212022: $860M20222023: $1.1B20232024: $1.3B20242025: $1.4B2025$1.4B
Net income
2019: $6M20192021: -$307M20212022: -$216M20222023: -$186M20232024: -$57M20242025: $10M2025$10M
Free cash flow
2019: $3M20192021: -$85M20212022: -$26M20222023: -$57M20232024: $86M20242025: $110M2025$110M
EPS (diluted)
2021: $-0.0020212022: $-0.6120222023: $-0.5120232024: $-0.1520242025: $0.022025$0.02

Income statement

Fiscal yearTTM202520242023202220212019
Revenue$1.7B$1.4B$1.3B$1.1B$860M$668M$213M
Gross profit———————
Operating income$104M$24M-$32M-$189M-$210M-$286M$15M
Net income$72M$10M-$57M-$186M-$216M-$307M$6M
EPS (diluted)$0.19$0.02$-0.15$-0.51$-0.61$-0.00—
R&D———————
Revenue growth—+13.9%+18.5%+22.8%+28.8%+214.1%—

Cash flow

Fiscal yearTTM202520242023202220212019
Operating cash flow$228M$146M$107M-$17M$53M$9M$17M
Capital spending-$48M-$36M-$22M-$41M-$79M-$94M-$14M
Free cash flow$179M$110M$86M-$57M-$26M-$85M$3M
Dividends paid—$0$0$0$0$0$0
Buybacks———————
Stock-based pay$70M$75M$76M$99M$187M$259M$54000

Balance sheet

Fiscal yearTTM202520242023202220212019
Cash—$249M$155M$79M$109M$148M$3M
Debt—$477M$488M$517M$485M$161M—
Equity—$1.5B$1.4B$1.4B$1.5B$1.5B-$166M
Total assets—$2.2B$2.1B$2.1B$2.2B$1.9B—
Shares (diluted)391M391M379M367M355M328M—

Margins and returns

Fiscal yearTTM202520242023202220212019
Gross margin———————
Operating margin6.2%1.7%-2.5%-17.9%-24.4%-42.9%7.2%
Net margin4.3%0.7%-4.6%-17.6%-25.1%-46.0%2.7%
FCF margin10.7%7.7%6.9%-5.4%-3.1%-12.7%1.3%
ROIC—0.9%-1.6%-8.8%-9.7%-15.5%—
ROE—0.6%-4.0%-13.0%-14.2%-19.9%-3.4%

Frequently asked questions

What is LifeStance Health Group’s annual revenue?

$1.4B in fiscal 2025 and $1.7B over the twelve months to September 30, 2026.

How much profit does LifeStance Health Group make?

Net income was $10M in fiscal 2025 (net margin 0.7%).

Is LifeStance Health Group’s revenue growing?

Yes: revenue rose 13.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.